A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques.

IF 6.9 1区 医学 Q1 IMMUNOLOGY
Fengwen Xu, Yu Huang, Yongzhi Hou, Yu Xie, Baoying Huang, Fei Zhao, Zhao Gao, Chen Chen, Jiaxun Wang, Shan Mei, Yamei Hu, Liming Wang, Liang Wei, Jingjing Zhang, Na Li, Zhe Cong, Jianrong Ma, Lin Zhu, Ting Chen, Jiahan Lu, Qiang Wei, Wenjie Tan, Jing Xue, Fei Guo
{"title":"A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques.","authors":"Fengwen Xu, Yu Huang, Yongzhi Hou, Yu Xie, Baoying Huang, Fei Zhao, Zhao Gao, Chen Chen, Jiaxun Wang, Shan Mei, Yamei Hu, Liming Wang, Liang Wei, Jingjing Zhang, Na Li, Zhe Cong, Jianrong Ma, Lin Zhu, Ting Chen, Jiahan Lu, Qiang Wei, Wenjie Tan, Jing Xue, Fei Guo","doi":"10.1038/s41541-025-01193-y","DOIUrl":null,"url":null,"abstract":"<p><p>Shortly after 2022, mpox again becomes a public health emergency of international concern as declared by the World Health Organization on August 14, 2024. Smallpox vaccines ACAM2000 and MVA-BN were approved for mpox prevention in several countries. However, the side effects of ACAM2000 and the limited supply of MVA call for the development of new mpox vaccines to prevent mpox and other orthopoxvirus infections. In this study, we engineered a new generation of attenuated and highly immunogenic vaccinia virus named dBTF based on the vaccinia Tiantan strain which is a replication-competent smallpox vaccine widely used in China. The dBTF vaccinia virus is impaired in replication and low in virulence, induces strong vaccinia virus-specific humoral and cellular immune responses. Importantly, single dose of dBTF vaccination effectively protects mice and cynomolgus macaques from mpox virus challenge. These results support the development of dBTF into a new generation of mpox and orthopoxvirus vaccines.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"10 1","pages":"134"},"PeriodicalIF":6.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-025-01193-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Shortly after 2022, mpox again becomes a public health emergency of international concern as declared by the World Health Organization on August 14, 2024. Smallpox vaccines ACAM2000 and MVA-BN were approved for mpox prevention in several countries. However, the side effects of ACAM2000 and the limited supply of MVA call for the development of new mpox vaccines to prevent mpox and other orthopoxvirus infections. In this study, we engineered a new generation of attenuated and highly immunogenic vaccinia virus named dBTF based on the vaccinia Tiantan strain which is a replication-competent smallpox vaccine widely used in China. The dBTF vaccinia virus is impaired in replication and low in virulence, induces strong vaccinia virus-specific humoral and cellular immune responses. Importantly, single dose of dBTF vaccination effectively protects mice and cynomolgus macaques from mpox virus challenge. These results support the development of dBTF into a new generation of mpox and orthopoxvirus vaccines.

一种新的减毒和高免疫原性正痘病毒疫苗可预防小鼠和猕猴的m痘。
2022年之后不久,世界卫生组织于2024年8月14日宣布麻疹再次成为国际关注的突发公共卫生事件。天花疫苗ACAM2000和MVA-BN在一些国家被批准用于预防m痘。然而,ACAM2000的副作用和MVA的有限供应要求开发新的m痘疫苗,以预防m痘和其他正痘病毒感染。在本研究中,我们以国内广泛使用的复制型牛痘天坛株为基础,设计了新一代高免疫原性的减毒牛痘病毒dBTF。dBTF牛痘病毒复制受损,毒力低,诱导强牛痘病毒特异性体液和细胞免疫反应。重要的是,单次接种dBTF疫苗可以有效地保护小鼠和食蟹猴免受m痘病毒的攻击。这些结果支持将dBTF开发成新一代mpox和正痘病毒疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NPJ Vaccines
NPJ Vaccines Immunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍: Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信